← Back to Search

Behavioural Intervention

aDOT-CEI for HIV/AIDS (YEHE Trial)

N/A
Recruiting
Led By Parya Saberi, PharmD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

YEHE Trial Summary

This trial aims to improve HIV treatment adherence among 18-29 year olds through automated directly observed therapy with incentives. Feasibility and acceptability are being assessed.

Who is the study for?
This trial is for young adults aged 18-29 with HIV who have an unsuppressed viral load and are on daily oral antiretroviral therapy. Participants must have access to a smartphone (except Samsung Galaxy S21 or iPhone 5SE), speak English, and be clients at AHF clinics in California or Florida.Check my eligibility
What is being tested?
The study tests an automated directly observed therapy paired with money rewards for taking HIV medication regularly (aDOT-CEI). It aims to see if this method is feasible, acceptable, and can help improve medication adherence among youth living with HIV.See study design
What are the potential side effects?
Since the intervention involves monitoring and incentives rather than a medical treatment, traditional side effects are not applicable. However, participants may experience privacy concerns or stress related to adherence tracking.

YEHE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability: App Recommendation
Acceptability: Client Satisfaction
Acceptability: Intervention Components
+5 more
Secondary outcome measures
ART Adherence
Monitoring of Behavior: Ease of use
Monitoring of Behavior: Frequency of App Related Issues
+2 more

YEHE Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
All YLWH who choose to enroll in the study will receive access to AiCure, the mobile health application. The participants will be asked to use the app for 3 months, during which the investigators will assess the feasibility and acceptability of AiCure.

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,525 Total Patients Enrolled
AiCureIndustry Sponsor
5 Previous Clinical Trials
168 Total Patients Enrolled
RTI InternationalOTHER
188 Previous Clinical Trials
875,934 Total Patients Enrolled

Media Library

aDOT-CEI (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05789875 — N/A
HIV/AIDS Research Study Groups: Intervention
HIV/AIDS Clinical Trial 2023: aDOT-CEI Highlights & Side Effects. Trial Name: NCT05789875 — N/A
aDOT-CEI (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05789875 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the eligibility criterion for this experiment inclusive of elderly individuals?

"This medical research is looking for volunteers aged between 18 years and 29 years."

Answered by AI

What is the upper limit of participants for this research endeavor?

"Affirmative. Clinicaltrials.gov affirms that this clinical experiment, initially posted on January 31st 2023, is actively enrolling patients. The study requires 30 volunteers to be recruited from a single medical facility."

Answered by AI

Are there currently any slots available for participants of this medical trial?

"Clinicaltrials.gov confirms that this investigation is still actively recruiting participants, having first been announced on the 31st of January 2023 and then updated most recently on 16th March 2021."

Answered by AI

What is the ultimate objective of this experiment?

"According to the trial sponsor, AiCure, this study's primary aim is to assess mean logins per week over 3 months. In addition, secondary objectives are being measured including self-reported ART adherence from a survey and mobile app data collected by AiCure platform tracking user behaviour (minutes in app) as well as ease of use via 7-point Likert scale responses."

Answered by AI

Under what conditions is participation in this research trial open?

"This clinical trial's consideration criteria involves HIV/AIDS and an age range of 18 to 29. The enrollment process is aiming for approximately 30 patients."

Answered by AI
~5 spots leftby Jul 2024